These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2948424)

  • 1. Effect of chronic hyperprolactinemia induced by sulpiride on plasma dehydroepiandrosterone (DHA) in normal men.
    Oseko F; Morikawa K; Nakano A; Note S; Endo J; Taniguchi A; Kono T; Imura H
    Andrologia; 1986; 18(5):523-8. PubMed ID: 2948424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of induced hyperprolactinemia on the plasma levels of C19 steroids in humans].
    Suzuki A; Kubota T; Oiyama H; Sono N; Nishi N
    Nihon Naibunpi Gakkai Zasshi; 1983 Jul; 59(7):1004-12. PubMed ID: 6226542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects.
    Schiebinger RJ; Chrousos GP; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1986 Jan; 62(1):202-9. PubMed ID: 2999177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic sulpiride-induced hyperprolactinemia on menstrual cycles of normal women.
    Oseko F; Morikawa K; Motohashi T; Aso T
    Obstet Gynecol; 1988 Aug; 72(2):267-71. PubMed ID: 3134632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic sulpiride-induced hyperprolactinemia on plasma testosterone and its responses to hCG in normal men.
    Oseko F; Oka N; Furuya H; Morikawa K
    J Androl; 1988; 9(4):231-3. PubMed ID: 3182393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of chronic hyperprolactinemia induced by sulpiride on the hypothalamo-pituitary-testicular axis in normal men.
    Oseko F; Note S; Morikawa K; Endo J; Taniguchi A; Imura H
    Fertil Steril; 1985 Jul; 44(1):106-11. PubMed ID: 3891423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperprolactinemia and 5-alpha-reductase activity.
    Noci I; Tantini C; Nardi E; Saltarelli O; Chelo E; Scarselli G; Bigazzi M; Messori A
    Acta Eur Fertil; 1986; 17(2):129-31. PubMed ID: 2943108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen feedback in normal and sulpiride-induced hyperprolactinemic postmenopausal women.
    Nishi T; Nakano R; Yagi S
    Horm Res; 1989; 32(5-6):193-7. PubMed ID: 2517493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
    Paparrigopoulos T; Liappas J; Tzavellas E; Mourikis I; Soldatos C
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):92-6. PubMed ID: 16938372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of experimental hyperprolactinemia and clomiphene on pituitary responsiveness to LHRH and TRH in men.
    Rönnberg L; Reinilä M; Ylikorkala O
    Andrologia; 1985; 17(4):364-8. PubMed ID: 3931501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sulpiride-induced hyperprolactinemia on human ovarian follicles during the late follicular phase.
    Sowa M; Tsuji K; Nakano R
    Fertil Steril; 1986 Dec; 46(6):1032-6. PubMed ID: 3096790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of ovarian LH receptor and serum hormone levels in rats with hyperprolactinemia induced by administration of ovine prolactin or sulpiride.
    Ota H; Wakizaka A; Fukushima M
    Tohoku J Exp Med; 1986 Feb; 148(2):213-27. PubMed ID: 3008378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subnormal plasma adrenal androgen levels in men with uremia.
    Zumoff B; Walter L; Rosenfeld RS; Strain JJ; Degen K; Strain GW; Levin J; Fukushima D
    J Clin Endocrinol Metab; 1980 Oct; 51(4):801-5. PubMed ID: 6448261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prolactin, ovarian and adrenal steroid hormone in relation to the vaginal opening in immature female rats].
    Miyakawa Z; Chiba H; Hirato K; Hosokawa T; Ishizuka Y; Yanaihara T
    Nihon Naibunpi Gakkai Zasshi; 1991 Jun; 67(6):710-20. PubMed ID: 1832389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal androgens in patients with chronic marked elevation of prolactin.
    Parker LN; Chang S; Odell WD
    Clin Endocrinol (Oxf); 1978 Jan; 8(1):1-5. PubMed ID: 146573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperprolactinemia after low dose of amisulpride.
    Kopecek M; Bares M; Svarc J; Dockery C; Horácek J
    Neuro Endocrinol Lett; 2004 Dec; 25(6):419-22. PubMed ID: 15665803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sulpiride induced hyperprolactinemia on testosterone secretion and metabolism before and after HCG in normal men.
    Bernini GP; Gasperi M; Franchi F; Luisi M
    J Endocrinol Invest; 1983 Aug; 6(4):287-91. PubMed ID: 6643949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-Trp6-luteinizing hormone-releasing hormone inhibits sulpiride-induced hyperprolactinemia in normal men.
    Rubio MA; Torres-Aleman I; Calle JR; Cabranes JA; Schally AV; Charro AL
    J Clin Endocrinol Metab; 1987 Aug; 65(2):368-9. PubMed ID: 2954994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary and testicular response to luteinizing hormone releasing hormone in normal and sulpiride-induced hyperprolactinaemic men.
    Nakano R; Yagi S; Nishi T
    Exp Clin Endocrinol; 1988 May; 91(2):191-6. PubMed ID: 3137082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired LH-RH release by estrogen in women with sulpiride-induced hyperprolactinemia.
    Aono T; Miyake A; Koike K; Tasaka K; Kurachi K
    Endocrinol Jpn; 1984 Oct; 31(5):571-5. PubMed ID: 6440785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.